A Study to Compare PK, PD and Safety of the AD-214 and AD-2141

Status:
Recruiting

Trial end date:
2022-05-01

Target enrollment:

Participant gender:

A study to compare safety, pharmacokinetics and pharmacodynamics of AD-214 to AD-2141 in healthy volunteers.

Phase 1

Addpharma Inc.